Colfax Corporation (CFX): Price and Financial Metrics


Colfax Corporation (CFX)

Today's Latest Price: $40.69 USD

0.05 (-0.12%)

Updated Jan 28 10:41am

Add CFX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 91 in Industrial - Machinery

See all "A" rated Strong Buy stocks

CFX Stock Summary

  • CFX's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 476.8 -- higher than 92.39% of US-listed equities with positive expected earnings growth.
  • With a year-over-year growth in debt of -43.45%, Colfax CORP's debt growth rate surpasses merely 7.34% of about US stocks.
  • Colfax CORP's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 30.13%, greater than the shareholder yield of 92.91% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Colfax CORP are TEX, THR, ANDE, ENV, and CUB.
  • CFX's SEC filings can be seen here. And to visit Colfax CORP's official web site, go to www.colfaxcorp.com.

CFX Stock Price Chart Interactive Chart >

Price chart for CFX

CFX Price/Volume Stats

Current price $40.69 52-week high $42.43
Prev. close $40.74 52-week low $12.23
Day low $40.69 Volume 384,523
Day high $42.15 Avg. volume 1,215,388
50-day MA $37.86 Dividend yield N/A
200-day MA $31.82 Market Cap 4.82B

Colfax Corporation (CFX) Company Bio


Colfax Corporation is a manufacturing and engineering company that provides gas- and fluid-handling and fabrication technology products and services to commercial and governmental customers around the world under the Howden, Colfax Fluid Handling and ESAB brands. The company was founded in 1860 and is based in Annapolis Junction, Maryland.

CFX Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$40.69$2.76 -93%

We started the process of determining a valid price forecast for Colfax CORP with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Colfax CORP ranked in the 10th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Colfax CORP, consider:

  • Its compound free cash flow growth rate, as measured over the past 5.52 years, is -0.17% -- higher than just 9.83% of stocks in our DCF forecasting set.
  • Colfax CORP's weighted average cost of capital (WACC) is 10%; for context, that number is higher than 70.62% of tickers in our DCF set.
  • Relative to other stocks in its sector (Industrials), Colfax CORP has a reliance on debt greater than 65.94% of them.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-93%
1%-93%
2%-93%
3%-93%
4%-93%
5%-93%

Want more companies with a valuation profile/forecast similar to that of Colfax CORP? See FLOW, ACM, AIR, BKNG, and GLG.


CFX Latest News Stream


Event/Time News Detail
Loading, please wait...

CFX Latest Social Stream


Loading social stream, please wait...

View Full CFX Social Stream

Latest CFX News From Around the Web

Below are the latest news stories about Colfax CORP that investors may wish to consider to help them evaluate CFX as an investment opportunity.

Colfax's subsidiary buys Trilliant Surgical

DJO, a subsidiary of Colfax (CFX), acquires Trilliant Surgical, a national provider of foot and ankle orthopedic implants.In addition to having a broad product portfolio covering the full universe of foot recon/fixation procedures, Trilliant Surgical is the only provider of the novel Arsenal Foot Plating System™.The acquisition supports DJO’s expansion...

Seeking Alpha | January 20, 2021

5 Industrial Stocks Near 52-Week Highs That Can Scale Higher

The industrial sector is gearing up for growth in 2021. ParkerHannifin (PH), Fortune Brands (FBHS), Reliance Steel (RS), Rexnord (RXN) and Colfax (CFX) are performing well and are set to grow.

Yahoo | January 13, 2021

Is Colfax (CFX) a Profitable Stock for Value Investors Now?

Let's see if Colfax (CFX) stock is a good choice for value-oriented investors right now from multiple angles.

Yahoo | January 8, 2021

Is There An Opportunity With Colfax Corporation's (NYSE:CFX) 37% Undervaluation?

How far off is Colfax Corporation ( NYSE:CFX ) from its intrinsic value? Using the most recent financial data, we'll...

Yahoo | January 6, 2021

Research Analysis on Cruciate Ligament Repair Procedures Market By 2020 Forecasting Competitors Like Xiros, Stryker, Medical Devices Business Services, Corin, Artelon, Smith+Nephew, Zimmer Biomet, Colfax Corporation

In reconstruction, the torn ligament is removed and replaced with a piece of tendon from another part of the knee or from a deceased donor. This surgery is an outpatient procedure performed through small incisions around the knee joint and

OpenPR | December 14, 2020

Read More 'CFX' Stories Here

CFX Price Returns

1-mo 10.93%
3-mo 49.65%
6-mo 39.92%
1-year 8.80%
3-year -0.12%
5-year 83.79%
YTD 6.41%
2020 5.11%
2019 74.07%
2018 -47.25%
2017 10.27%
2016 53.88%

Continue Researching CFX

Here are a few links from around the web to help you further your research on Colfax CORP's stock as an investment opportunity:

Colfax CORP (CFX) Stock Price | Nasdaq
Colfax CORP (CFX) Stock Quote, History and News - Yahoo Finance
Colfax CORP (CFX) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8108 seconds.